Dr Lal Pathlabs Ltd Quarterly Results
Q2 FY26-27 Results Summary
Revenue
The revenue stands at ₹873.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 9.55 per cent from ₹797.70 crore. This corresponds to a year-on-year *(YoY) growth of 19.61 per cent.
Operating Profit
Operating Profit stands at ₹280.10 crore, reflecting a quarter-on-quarter *(QoQ) increase of 13.17 per cent from ₹247.50 crore. This corresponds to a year-on-year *(YoY) growth of 24.99 per cent.
PBDT
PBDT stands at ₹307.40 crore, reflecting a quarter-on-quarter *(QoQ) increase of 12.56 per cent from ₹273.10 crore. This corresponds to a year-on-year *(YoY) growth of 25.93 per cent.
Profit Before Tax
Profit Before Tax stands at ₹260.50 crore, reflecting a quarter-on-quarter *(QoQ) increase of 13.90 per cent from ₹228.70 crore. This corresponds to a year-on-year *(YoY) growth of 27.95 per cent.
Net Profit
Net Profit stands at ₹193.90 crore, reflecting a quarter-on-quarter *(QoQ) increase of 13.72 per cent from ₹170.50 crore. This represents a 27.40 per cent year-on-year *(YoY) growth for the same year.
- YoY compares a quarter to the same period last year, and QoQ compares it to the previous quarter.
Dr Lal Pathlabs Ltd News
Dr Lal Pathlabs Ltd Earnings
- YOY
- QOQ
Dr Lal Pathlabs Ltd Earning Charts
Revenue from Operations
in ₹ cr
EBITDA
in ₹ cr
Profit before Tax
in ₹ cr
Net Profit
in ₹ cr
Dr Lal Pathlabs Ltd Research Reports
Dr Lal Pathlabs Ltd Financial Reports
Dr Lal Pathlabs Ltd Stock Prices Compare with Peers
| Company | 1 Day | 1 Week | 1 month | 3 month | 6 month | 1 Year |
|---|---|---|---|---|---|---|
| Dr Lal Pathlabs | -3.26% | 3.89% | 0.80% | 1.54% | 25.17% | 26.58% |
| Fortis Health. | 3.68% | 7.89% | 5.11% | -14.58% | -13.46% | -19.64% |
| Narayana Hrudaya | -0.99% | 3.98% | 10.80% | 1.39% | 2.59% | 5.51% |
| Global Health | -1.42% | 7.05% | 7.43% | -4.45% | 14.48% | 11.09% |
| Krishna Institu. | -1.24% | 1.96% | 5.88% | -9.37% | 3.88% | 0.98% |
| Syngene Intl. | -0.81% | 0.38% | 14.97% | 2.69% | -11.74% | -32.80% |
| Poly Medicure | 1.10% | 8.67% | 0.16% | -4.41% | -3.68% | -14.56% |
Company Info
Company Information
Chairman cum Managing Director : Arvind Lal
Whole-time Director : Vandana Lal
Whole Time Director & CEO : Om Prakash Manchanda
Director : Rahul Sharma
Independent Director : Arun Duggal
Independent Director : Anoop Mahendra Singh
Independent Director : Sunil Varma
Independent Director : Harneet Singh Chandhoke
Independent Director : Saurabh Srivastava
Company Secretary : Rajat Kalra